532 research outputs found
Modern Views of Machine Learning for Precision Psychiatry
In light of the NIMH's Research Domain Criteria (RDoC), the advent of
functional neuroimaging, novel technologies and methods provide new
opportunities to develop precise and personalized prognosis and diagnosis of
mental disorders. Machine learning (ML) and artificial intelligence (AI)
technologies are playing an increasingly critical role in the new era of
precision psychiatry. Combining ML/AI with neuromodulation technologies can
potentially provide explainable solutions in clinical practice and effective
therapeutic treatment. Advanced wearable and mobile technologies also call for
the new role of ML/AI for digital phenotyping in mobile mental health. In this
review, we provide a comprehensive review of the ML methodologies and
applications by combining neuroimaging, neuromodulation, and advanced mobile
technologies in psychiatry practice. Additionally, we review the role of ML in
molecular phenotyping and cross-species biomarker identification in precision
psychiatry. We further discuss explainable AI (XAI) and causality testing in a
closed-human-in-the-loop manner, and highlight the ML potential in multimedia
information extraction and multimodal data fusion. Finally, we discuss
conceptual and practical challenges in precision psychiatry and highlight ML
opportunities in future research
Recommended from our members
Predicting risk for Alcohol Use Disorder using longitudinal data with multimodal biomarkers and family history: a machine learning study.
Predictive models have succeeded in distinguishing between individuals with Alcohol use Disorder (AUD) and controls. However, predictive models identifying who is prone to develop AUD and the biomarkers indicating a predisposition to AUD are still unclear. Our sample (n = 656) included offspring and non-offspring of European American (EA) and African American (AA) ancestry from the Collaborative Study of the Genetics of Alcoholism (COGA) who were recruited as early as age 12 and were unaffected at first assessment and reassessed years later as AUD (DSM-5) (n = 328) or unaffected (n = 328). Machine learning analysis was performed for 220 EEG measures, 149 alcohol-related single nucleotide polymorphisms (SNPs) from a recent large Genome-wide Association Study (GWAS) of alcohol use/misuse and two family history (mother DSM-5 AUD and father DSM-5 AUD) features using supervised, Linear Support Vector Machine (SVM) classifier to test which features assessed before developing AUD predict those who go on to develop AUD. Age, gender, and ancestry stratified analyses were performed. Results indicate significant and higher accuracy rates for the AA compared with the EA prediction models and a higher model accuracy trend among females compared with males for both ancestries. Combined EEG and SNP features model outperformed models based on only EEG features or only SNP features for both EA and AA samples. This multidimensional superiority was confirmed in a follow-up analysis in the AA age groups (12-15, 16-19, 20-30) and EA age group (16-19). In both ancestry samples, the youngest age group achieved higher accuracy score than the two other older age groups. Maternal AUD increased the model's accuracy in both ancestries' samples. Several discriminative EEG measures and SNPs features were identified, including lower posterior gamma, higher slow wave connectivity (delta, theta, alpha), higher frontal gamma ratio, higher beta correlation in the parietal area, and 5 SNPs: rs4780836, rs2605140, rs11690265, rs692854, and rs13380649. Results highlight the significance of sampling uniformity followed by stratified (e.g., ancestry, gender, developmental period) analysis, and wider selection of features, to generate better prediction scores allowing a more accurate estimation of AUD development
Contributions to the study of Austism Spectrum Brain conectivity
164 p.Autism Spectrum Disorder (ASD) is a largely prevalent neurodevelopmental condition with a big social and economical impact affecting the entire life of families. There is an intense search for biomarkers that can be assessed as early as possible in order to initiate treatment and preparation of the family to deal with the challenges imposed by the condition. Brain imaging biomarkers have special interest. Specifically, functional connectivity data extracted from resting state functional magnetic resonance imaging (rs-fMRI) should allow to detect brain connectivity alterations. Machine learning pipelines encompass the estimation of the functional connectivity matrix from brain parcellations, feature extraction and building classification models for ASD prediction. The works reported in the literature are very heterogeneous from the computational and methodological point of view. In this Thesis we carry out a comprehensive computational exploration of the impact of the choices involved while building these machine learning pipelines
An Overview on Artificial Intelligence Techniques for Diagnosis of Schizophrenia Based on Magnetic Resonance Imaging Modalities: Methods, Challenges, and Future Works
Schizophrenia (SZ) is a mental disorder that typically emerges in late
adolescence or early adulthood. It reduces the life expectancy of patients by
15 years. Abnormal behavior, perception of emotions, social relationships, and
reality perception are among its most significant symptoms. Past studies have
revealed the temporal and anterior lobes of hippocampus regions of brain get
affected by SZ. Also, increased volume of cerebrospinal fluid (CSF) and
decreased volume of white and gray matter can be observed due to this disease.
The magnetic resonance imaging (MRI) is the popular neuroimaging technique used
to explore structural/functional brain abnormalities in SZ disorder owing to
its high spatial resolution. Various artificial intelligence (AI) techniques
have been employed with advanced image/signal processing methods to obtain
accurate diagnosis of SZ. This paper presents a comprehensive overview of
studies conducted on automated diagnosis of SZ using MRI modalities. Main
findings, various challenges, and future works in developing the automated SZ
detection are described in this paper
Multimodal neuroimaging signatures of early cART-treated paediatric HIV - Distinguishing perinatally HIV-infected 7-year-old children from uninfected controls
Introduction: HIV-related brain alterations can be identified using neuroimaging modalities such as proton magnetic resonance spectroscopy (1H-MRS), structural magnetic resonance imaging (sMRI), diffusion tensor imaging (DTI), and functional MRI (fMRI). However, few studies have combined multiple MRI measures/features to identify a multivariate neuroimaging signature that typifies HIV infection. Elastic net (EN) regularisation uses penalised regression to perform variable selection, shrinking the weighting of unimportant variables to zero. We chose to use the embedded feature selection of EN logistic regression to identify a set of neuroimaging features characteristic of paediatric HIV infection. We aimed to determine 1) the most useful features across MRI modalities to separate HIV+ children from HIV- controls and 2) whether better classification performance is obtained by combining multimodal MRI features rather than using features from a single modality. Methods: The study sample comprised 72 HIV+ 7-year-old children from the Children with HIV Early Antiretroviral Therapy (CHER) trial in Cape Town, who initiated combination antiretroviral therapy (cART) in infancy and had their viral loads suppressed from a young age, and 55 HIV- control children. Neuroimaging features were extracted to generate 7 MRI-derived sets. For sMRI, 42 regional brain volumes (1st set), mean cortical thickness and gyrification in 68 brain regions (2nd and 3rd set) were used. For DTI data: radial (RD), axial (AD), mean (MD) diffusivities, and fractional anisotropy (FA) in each of 20 atlas regions were extracted for a total of 80 DTI features (4th set). For 1H-MRS, concentrations of 14 metabolites and their ratios to creatine in the basal ganglia, peritrigonal white matter, and midfrontal gray matter voxels (5th, 6th and 7th set) were considered. A logistic EN regression model with repeated 10-fold cross validation (CV) was implemented in R, initially on each feature set separately. Sex, age and total intracranial volume (TIV) were included as confounders with no shrinkage penalty. For each model, the classification performance for HIV+ vs HIV- was assessed by computing accuracy, specificity, sensitivity, and mean area under the receiver operator characteristic curve (AUC) across 10 CV folds and 100 iterations. To combine feature sets, the best performing set was concatenated with each of the other sets and further EN regressions were run. The combination giving the largest AUC was combined with each of the remaining sets until there was no further increase in AUC. Two concatenation techniques were explored: nested and non-nested modelling. All models were assessed for their goodness of fit using χ 2 likelihood ratio tests for non-nested models and Akaike information criterion (AIC) for nested models. To identify features most useful in distinguishing HIV infection, the EN model was retrained on all the data, to find features with non-zero weights. Finally, multivariate imputation using chained equations (MICE) was explored to investigate the effect of increased sample size on classification and feature selection. Results: The best performing modality in the single modality analysis was sMRI volume
Role of deep learning in infant brain MRI analysis
Deep learning algorithms and in particular convolutional networks have shown tremendous success in medical image analysis applications, though relatively few methods have been applied to infant MRI data due numerous inherent challenges such as inhomogenous tissue appearance across the image, considerable image intensity variability across the first year of life, and a low signal to noise setting. This paper presents methods addressing these challenges in two selected applications, specifically infant brain tissue segmentation at the isointense stage and presymptomatic disease prediction in neurodevelopmental disorders. Corresponding methods are reviewed and compared, and open issues are identified, namely low data size restrictions, class imbalance problems, and lack of interpretation of the resulting deep learning solutions. We discuss how existing solutions can be adapted to approach these issues as well as how generative models seem to be a particularly strong contender to address them
- …